Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, March 18, 2016 4:33:30 PM
bearish 72.68
## source: finance.yahoo.com
$NVS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NVS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NVS/company-info
Ticker: $NVS
OTC Market Place: Not Available
CIK code: 0001114448
Company name: Novartis AG
Company website: http://www.novartis.com
Incorporated In: Switzerland
Business Description:
$NVS share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$NVS extra dd links
Company name: Novartis AG
Company website: http://www.novartis.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVS/news - http://finance.yahoo.com/q/h?s=NVS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Novartis+AG&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Novartis+AG
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Novartis+AG&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.novartis.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.novartis.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.novartis.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVS
$NVS DD Notes ~ http://www.ddnotesmaker.com/NVS
Recent NVS News
- Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/07/2024 11:00:11 AM
- Apple Loses Market Share in China, GM Surges in Pre-Market Following Upward Revisions for 2024 Projections, and More News • IH Market News • 04/23/2024 11:25:34 AM
- New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN) • PR Newswire (US) • 04/15/2024 06:00:00 PM
- Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer • GlobeNewswire Inc. • 04/11/2024 11:00:49 AM
- Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News • IH Market News • 04/10/2024 11:13:48 AM
- New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting • PR Newswire (US) • 04/06/2024 08:16:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/15/2024 09:15:21 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 02/06/2024 09:52:29 PM
- Boeing Faces Strike Threat, Palantir Up 18% After Recording its First Profitable Year, and More • IH Market News • 02/06/2024 11:14:00 AM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 02/05/2024 10:06:59 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 07:18:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/31/2024 12:44:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/31/2024 12:43:49 PM
- Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). • Edgar (US Regulatory) • 01/31/2024 12:42:06 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/31/2024 12:38:06 PM
- Walmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and More • IH Market News • 01/31/2024 11:28:17 AM
- Sandoz to Acquire Cimerli Business from Coherus for $170 Million • Dow Jones News • 01/22/2024 06:59:00 AM
- Wall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and More • IH Market News • 01/12/2024 11:10:50 AM
- Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal • Dow Jones News • 01/11/2024 06:02:00 PM
- Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal • Dow Jones News • 01/08/2024 06:43:00 PM
- Novartis on Track for Record High Close -- Data Talk • Dow Jones News • 01/08/2024 03:41:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 11:13:40 AM
- Novartis's Scemblix Drug Meets Main Goals in Late-Stage Leukemia Trial • Dow Jones News • 01/08/2024 07:01:00 AM
- Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant • Dow Jones News • 01/05/2024 03:15:00 PM
- Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration • Dow Jones News • 01/02/2024 12:46:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM